- AKRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $141.2 million.
- AKRX is down 2.1% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AKRX with the Ticky from Trade-Ideas. See the FREE profile for AKRX NOW at Trade-Ideas More details on AKRX: Akorn, Inc. develops, manufactures, and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products in the United States and internationally. It operates through two segments, Prescription Pharmaceuticals and Consumer Health. AKRX has a PE ratio of 126.5. Currently there are 9 analysts that rate Akorn a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for Akorn has been 2.4 million shares per day over the past 30 days. Akorn has a market cap of $4.9 billion and is part of the health care sector and drugs industry. Shares are up 18.8% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.